Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11081	Companies
243115	Keywords
171254	Articles
130874	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years 3 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development

Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years 3 months ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires

Biophytis Accord BIO101 Blanver Am\u00e9rique Latine
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years 3 months ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€

Biophytis Amérique Latine Accord De Licence BIO101 Blanver
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years 3 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced

Biophytis Latin America BIO101 Exclusive Rights Blanver
BRIEF

published on 06/20/2024 at 01:15, 2 years 3 months ago

Biophytis prolonge son contrat avec Atlas pour financer ses activités cliniques

Biophytis Biotechnologie Financement Obligations Convertibles Atlas
BRIEF

published on 06/20/2024 at 01:15, 2 years 3 months ago

Biophytis extends its contract with Atlas to finance its clinical activities

Biophytis Biotechnology Convertible Bonds Funding Atlas
PRESS RELEASE

published on 06/20/2024 at 01:10, 2 years 3 months ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités. Renouvellement de l'accord de financement obligataire pour le lancement de programmes cliniques OBA et MYODA

Contrat Biophytis Financement Atlas OBA
PRESS RELEASE

published on 06/20/2024 at 01:10, 2 years 3 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends financing agreement with Atlas, ensures funding for clinical programs OBA in obesity and MYODA in DMD. Details on the contract amendment and risk factors

Biophytis Atlas Financing Agreement Clinical Programs Risk Factors
BRIEF

published on 06/19/2024 at 23:05, 2 years 3 months ago

Biophytis prolonge son contrat avec Atlas pour le financement de ses activités

Biophytis Biotechnologie Financement ORNANE Atlas
BRIEF

published on 06/19/2024 at 23:05, 2 years 3 months ago

Biophytis Extends Financing Contract with Atlas

Biophytis Biotechnology Financing Clinical Trials Atlas

Accesswire

Published on 09/25/2026 at 00:30, 3 hours 22 minutes ago

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 3 hours 37 minutes ago

CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 5 hours 51 minutes ago

Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 17:45, 10 hours 7 minutes ago

Jo-Jo Announces Resignation of Director
Published on 09/24/2026 at 14:55, 12 hours 57 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 02:45, 1 hour 7 minutes ago

Huagui Group: un acteur mondial sur deux marchés aquatiques de plus de 100 milliards de RMB, tandis que la racine de lotus de Honghu se classe au premier rang pour sa teneur en antioxydants
Published on 09/25/2026 at 02:45, 1 hour 7 minutes ago

Huagui Group: A Global Player Across Two RMB100-Billion Aquatic Markets, as Honghu Lotus Root Ranks No. 1 in Antioxidant Content
Published on 09/24/2026 at 20:29, 7 hours 23 minutes ago

EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 8 hours 52 minutes ago

HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 9 hours 11 minutes ago

EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares

Les Echos

Published on 09/24/2026 at 18:31, 9 hours 21 minutes ago

LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:10, 9 hours 42 minutes ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 9 hours 52 minutes ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 9 hours 52 minutes ago

GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/24/2026 at 18:00, 9 hours 52 minutes ago

i2S : Résultats 1er semestre 2026

View all LES ECHOS COMFI WIRE